United States · Seed startup

Who invested in Kereos

3 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Follow Kereos and see its new rounds in your feed.Start following

Funding summaryUpdated 31 Oct 2026

$7.7Mraised across 3 rounds since 2009, from 3 sources

$887KDebt$5.7MVenture$1.1MSeed

Latest round: Seed, $1.1MJan 2012
Biggest round: $5.7MVenture · May 2010
Investors: 0

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201020112012

$887KDebt$5.7MVenture$1.1MSeed

First round: Debt, $887K
Biggest round: $5.7M
Usual gap between rounds: 20 months

The rounds

Jan 2012
Seed$1.1M
No investor was named in the report.
Reported by sec.govSEC filing: $1.1M sold, first sale Sept 2011
May 2010
Venture$5.7M
No investor was named in the report.
Reported by sec.govSEC filing: $5.7M sold, first sale Apr 2010
Jun 2009
Debt$887K
No investor was named in the report.
From a historical funding recordSEC filing: $887K sold, first sale Jun 2009

Founders and team

From the SEC filings it signed: 1 on the team.

Phillip M. BucklerExecutive Officeri

On the board, as filediFred A. SchwarzerGary A. StevensonGregory R. JohnsonJohn D. RiceMichael D. LobergSamuel A. Wickline

Also claim to have backed them

This firm lists Kereos as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Apjohn Ventures Fund, LPVC firmPer its own site